These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7851799)

  • 21. [Recommendations for estrogen and progesterone replacement in climacteric and postmenopause. 33. Workshop of the "Zurich Discussion Circle", October 2004].
    Birkhäuser M; Braendle W; Keller PJ; Kiesel L; Kuhl H; Neulen J
    Gynakol Geburtshilfliche Rundsch; 2006; 46(1-2):53-7. PubMed ID: 16452821
    [No Abstract]   [Full Text] [Related]  

  • 22. Topical vaginal estrogen therapy in managing postmenopausal urinary symptoms: a reality or a gimmick?
    Ewies AA; Alfhaily F
    Climacteric; 2010 Oct; 13(5):405-18. PubMed ID: 20670198
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women.
    Dobs AS; Nguyen T; Pace C; Roberts CP
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1509-16. PubMed ID: 11932273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Hormone replacement therapy: practical aspects].
    Sonigo C; Dray G; Chabbert-Buffet N
    J Gynecol Obstet Biol Reprod (Paris); 2012 Nov; 41(7 Suppl):F3-12. PubMed ID: 23062744
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correspondence (letter to the editor): Do not forget estrogen therapy.
    Wenderlein MJ
    Dtsch Arztebl Int; 2012 Oct; 109(42):714; author reply 714. PubMed ID: 23264823
    [No Abstract]   [Full Text] [Related]  

  • 26. Is hormone replacement therapy (estrogen plus progestin) effective for the treatment of urinary incontinence in postmenopausal women?
    Easton BT
    J Fam Pract; 2001 May; 50(5):470. PubMed ID: 11350716
    [No Abstract]   [Full Text] [Related]  

  • 27. Cardiovascular system and estrogen in menopause.
    Carbonel AAF; Simões RS; Girão MJBC; Soares Júnior JM; Baracat EC
    Rev Assoc Med Bras (1992); 2020 May; 66(2):97-98. PubMed ID: 32428138
    [No Abstract]   [Full Text] [Related]  

  • 28. Action of estrogens in the aging brain: dementia and cognitive aging.
    Henderson VW
    Biochim Biophys Acta; 2010 Oct; 1800(10):1077-83. PubMed ID: 19913598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen effects on the brain.
    Small GW
    J Gend Specif Med; 1998; 1(2):23-7. PubMed ID: 11281008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
    [No Abstract]   [Full Text] [Related]  

  • 31. Estrogen treatment affects brain functioning after menopause.
    Bayer U; Hausmann M
    Menopause Int; 2011 Dec; 17(4):148-52. PubMed ID: 22120942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of hormones on urinary incontinence in postmenopausal women.
    Quinn SD; Domoney C
    Climacteric; 2009 Apr; 12(2):106-13. PubMed ID: 19259853
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of local estrogen therapy in the management of pelvic floor disorders.
    Tzur T; Yohai D; Weintraub AY
    Climacteric; 2016 Apr; 19(2):162-71. PubMed ID: 26830033
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Joint position statement of Polish Gynecologic Society, Polish Cardiological Society, and Polish Menopause and Andropause Society on the effect of hormone replacement therapy on cardiovascular system].
    Kornacewicz-Jach Z; Czarnecka D; Rynkiewicz A; Kotarski J; Paszkowski T; Pertyński T; Debski R; Wielgoś M
    Kardiol Pol; 2009 Jan; 67(1):72-6. PubMed ID: 19253195
    [No Abstract]   [Full Text] [Related]  

  • 35. Trajectories and phenotypes with estrogen exposures across the lifespan: What does Goldilocks have to do with it?
    Koebele SV; Bimonte-Nelson HA
    Horm Behav; 2015 Aug; 74():86-104. PubMed ID: 26122297
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Post menopausal hormone therapy today.
    Rice VM
    Ethn Dis; 2005; 15(2 Suppl 2):S34-9. PubMed ID: 15822836
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of a soy-based dietary supplement compared with low-dose hormone therapy on the urogenital system: a randomized, double-blind, controlled clinical trial.
    Carmignani LO; Pedro AO; Montemor EB; Arias VA; Costa-Paiva LH; Pinto-Neto AM
    Menopause; 2015 Jul; 22(7):741-9. PubMed ID: 25423326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen use and postmenopausal women: a basis for informed decisions. NIH Consensus Development.
    Gastel B; Cornoni-Huntley J; Brody JA
    J Fam Pract; 1980 Nov; 11(6):851-60. PubMed ID: 7005387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of estrogen therapy in men.
    Sayed Y; Taxel P
    Curr Opin Pharmacol; 2003 Dec; 3(6):650-4. PubMed ID: 14644018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-dose estrogen in urogenital ageing.
    Heimer G
    Gerontology; 1994; 40 Suppl 3():3-5. PubMed ID: 7851800
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.